Edition:
United States

Admedus Ltd (AHZ.AX)

AHZ.AX on Australia Stock Exchange

0.25AUD
20 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.25
Open
$0.25
Day's High
$0.25
Day's Low
$0.25
Volume
84,619
Avg. Vol
305,142
52-wk High
$0.44
52-wk Low
$0.22

Chart for

About

Admedus Limited is a healthcare company, which develops, commercializes and distributes medical technologies and devices. The Company is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The Company operates... (more)
No analyst recommendations are available for .

Overall

Beta: 1.01
Market Cap(Mil.): $63.70
Shares Outstanding(Mil.): 254.80
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 33.06 16.52
EPS (TTM): -- -- --
ROI: -- 13.87 11.32
ROE: -- 16.68 15.18

BRIEF-Admedus announces exclusive supply agreement with 4C Medical

* Deal will add cardiovascular tissue engineering from Admedus to 4C Medical's transcatheter mitral regurgitation treatment technology Source text for Eikon: Further company coverage:

Aug 30 2017

BRIEF-Admedus posts full year sales of $22.3mln

* FY loss for year attributable to members down $12.312 mln Source text for Eikon: Further company coverage:

Aug 30 2017

BRIEF-Admedus receives FDA clearance for Cardiocel 3D

* Admedus receives FDA clearance for cardiocel 3d-ahz.ax Source text for Eikon: Further company coverage:

May 01 2017

Earnings vs. Estimates